Published: November 2024
Over the years, various technological advances and discoveries have significantly changed the practice of medicine. One such advancement that came into light was the development of cell-based therapies, which have demonstrated significant therapeutic potential and are devoid of most of the toxicity issues, which are associated with conventional pharmacological interventions; consequently, driving the growth of cell therapy manufacturing market.We analyzed over 190 cell therapy manufacturing companies that are engaged in manufacturing of cell therapies. In this article, discover five top cell therapy manufacturing companies and their capabilities in cell therapy manufacturing market.
Cell therapies are based on the premise that the patient’s own cells (autologous), or those from a healthy donor (allogeneic), can be genetically re-programmed to combat various diseases. As anticipated, these therapies have emerged as viable alternatives to traditional treatment options, such as small molecule drugs. It is worth mentioning that the past few decades have witnessed several advances in this domain, particularly in the manufacturing processes of such therapies. However, even the latest and the most promising advances in modern medicine have their own set of challenges and risks, which need to be addressed to ensure continued growth. Gradually, with the introduction of new reforms in legislation pertaining to cell-based therapies, and rapid advancements in clinical development, there has been a significant increase in the interest of stakeholders in this domain. Additionally, the cell therapy market has witnessed the entry of several novel players with new technology solutions, aimed at improving and upgrading the existing technology. Given the personalized nature of these treatment options, they are highly specific and are characterized by short treatment durations and largely positive outcomes. The promising therapeutic potential of such therapies has led to a significant increase in investments towards the development and commercialization of these therapies.
Roots Analysis has conducted an exhaustive study on Cell Therapy Manufacturing Market featuring the current market landscape and future opportunity for the companies engaged in manufacturing cell therapies, over a span of 11 years.
Below, we have listed (in alphabetical order), the top five cell therapy manufacturing companies:

Interested in exploring all 190+ Cell Therapy Manufacturing Companies and their recent initiatives?
Let us deep dive to understand the activity of the five top cell therapy manufacturing companies (based on general understanding) in the cell therapy manufacturing market. It is essential to note that the selection of top players can differ substantially according to the defined criteria.
1. AGC Biologics
AGC Biologics is a leading global biopharmaceutical CDMO, serving the biotechnology and pharmaceutical sectors. With facilities in the US, Europe, and Asia, AGC Biologics offers a comprehensive suite of services for the development and manufacturing of biopharmaceuticals, including cell line development, process development, and cGMP manufacturing. Their expertise spans a wide range of therapeutic modalities, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies.
AGC Biologics: Company Overview
|
Key Parameters |
Description |
| Company Logo | ![]() |
| Year of Establishment | 2018 |
| Number of Employees | 1,001-5,000 |
| Headquarters | US |
The company is likely to acquire additional manufacturing facilities in order to further expand its existing capabilities and cater to the increasing demands of its global clientele. In August 2021, the company acquired the state-of-the-art cell and gene therapy commercial manufacturing facility in Longmont, Colorado in order to expand its end-to-end cell and gene therapy (C>) offerings.
Further details on recent initiatives taken by AGC Biologics and other cell therapy manufacturing companies have been provided in detail in the report.
2. Charles River Laboratories
Charles River Laboratories is a pharmaceutical firm, providing essential products and services to various life sciences industry. With a focus on drug discovery and development, the company offers a comprehensive suite of research models, preclinical services, and support to pharmaceutical, biotechnology, and academic organizations worldwide. It is worth highlighting that, in March 2021, the company acquired Cognate Bioservices for a total consideration of USD 875 million.
Charles River Laboratories: Company Details
|
Particulars |
Specifications |
| Company Logo | ![]() |
| Year of Establishment | 1947 |
| Number of Employees | 10,001+ |
| Headquarters | US |
In the coming years, we anticipate the company to launch more products to support advanced therapy medicinal product (ATMPs) developers. In January 2023, the firm launched eXpDNA plasmid manufacturing platform to optimize plasmid development and manufacturing operations for cell therapy, gene therapy and nucleic acid vaccine developers.
Further details on recent initiatives taken by Charles River Laboratories and other cell therapy manufacturing companies have been provided in detail in the report.
3. BioNTech
BioNTech is a pioneering biotechnology company focused on developing personalized immunotherapies for cancer and other serious diseases. Founded in 2008 in Mainz, Germany, the company leverages its mRNA technology to develop novel cell therapy treatments and vaccines. Through collaboration with Pfizer, they achieved the first authorized COVID-19 mRNA vaccine.
BioNTech: Company Details
|
Particulars |
Specifications |
| Company Logo | ![]() |
| Year of Establishment | 1997 |
| Number of Employees | 201-500 |
| Headquarters | Germany |
The company is expected to continue to further expand its existing facilities and capabilities in order to accommodate the growing demands of its clients. In August 2023, BioNTech acquired Tunisian-based start-up, named InstaDeep in order to strengthen its pioneering position in the field of AI-powered drug discovery, design and development.
Further details on recent initiatives taken by BioNTech and other cell therapy manufacturing companies have been provided in detail in the report.
4. Cell and Gene Therapy Catapult
Cell and Gene Therapy Catapult is a leading organization in the UK dedicated to advancing the development of cell and gene therapies. Established in 2012, it provides infrastructure, expertise, and collaboration opportunities to accelerate the translation of promising research into commercial products. With state-of-the-art facilities and a multidisciplinary team of experts, the firm supports various companies and academic institutions at all stages of the therapy development process.
Cell and Gene Therapy Catapult: Company Overview
|
Particulars |
Specifications |
| Company Logo | ![]() |
| Year of Establishment | 2012 |
| Number of Employees | 201-500 |
| Headquarters | UK |
In November 2021, the company entered into a joint venture with Deep Science Ventures to develop innovative approaches addressing challenges associated with ATMPs manufacturing.
Further details on recent initiatives taken by Cell and Gene Therapy Catapult and other cell therapy manufacturing companies have been provided in detail in the report.
5. Cell Therapies
Cell Therapies is a pioneering biotechnology firm specializing in the development and commercialization of cutting-edge cell therapies. Established with a mission to advance regenerative medicines, the company operates at the forefront of scientific innovation, leveraging state-of-the-art technologies and a multidisciplinary approach. Their expertise spans the entire spectrum of therapy development, from research and development to manufacturing and distribution.
Cell Therapies: Company Overview
|
Particulars |
Specifications |
| Company Logo | ![]() |
| Year of Establishment | 2003 |
| Number of Employees | 201-500 |
| Headquarters | Germany |
The company is likely to continue seeking partnership opportunities with other leading players for the manufacturing of cell therapies. In November 2023, Cell Therapies entered into a strategic partnership with Arovella Therapeutics in order to develop a manufacturing process for the later company’s drug candidate to for cancer clinical trials.
Further details on recent initiatives taken by Cell Therapies and other cell therapy manufacturing companies have been provided in detail in the report.
The above presentation features five top cell therapy manufacturing companies selected from a pool of over 190 players that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources